Scarica l'app Stockscreener
1.3607
0.33%
0.0393
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché MBIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.40
Aprire:
$1.41
Volume 24 ore:
20,085
Relative Volume:
0.07
Capitalizzazione di mercato:
$3.86M
Reddito:
-
Utile/perdita netta:
$-23.42M
Rapporto P/E:
-0.0174
EPS:
-78
Flusso di cassa netto:
$-16.67M
1 W Prestazione:
-5.09%
1M Prestazione:
-49.84%
6M Prestazione:
-89.60%
1 anno Prestazione:
-97.18%
Intervallo 1D:
$1.35
$1.41
Intervallo di 1 settimana:
$1.35
$1.6003
Portata 52W:
$1.35
$67.00
Mustang Bio Inc Stock (MBIO) Company Profile
Nome
Mustang Bio Inc
Settore
Industria
Telefono
(781) 652-4500
Indirizzo
377 PLANTATION STREET, WORCESTER, NY
Confronta MBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
1.37 | 3.86M | 0 | -23.42M | -16.67M | -78.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
510.96 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.43 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.90 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.19 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.79 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-05-18 | Iniziato | BTIG Research | Buy |
| 2020-10-02 | Iniziato | B. Riley FBR | Buy |
| 2019-11-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-08-13 | Iniziato | H.C. Wainwright | Buy |
| 2019-06-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Mustang Bio Inc Borsa (MBIO) Ultime notizie
Car T Cell Therapy Market Demand, Statistics, Future Growth and Outlook 2025-2032 | Mustang Bio, Fate Therapeutics - openPR
Mustang Bio stock plunges to 52-week low of $1.43 By Investing.com - Investing.com Australia
Mustang Bio stock plunges to 52-week low of $1.43 - Investing.com India
Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga
Mustang Bio Regains Nasdaq Compliance, Secures Position For Cell Therapy Advancements - Nasdaq
Mustang Bio meets Nasdaq’s equity listing requirements By Investing.com - Investing.com Canada
Mustang Bio meets Nasdaq’s equity listing requirements - Investing.com India
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - The Manila Times
Mustang Bio Overcomes Delisting Threat: What This Nasdaq Compliance Means for Investors - StockTitan
BRIEF—Mustang Bio sells assets; focuses on MB-109, MB-108 and MB-101 - The Pharma Letter
Mustang Bio (MBIO) Projected to Post Earnings on Monday - Defense World
Mustang Bio stock plunges 29% on lease termination news - MSN
Mustang Bio stock plunges to 52-week low at $2 By Investing.com - Investing.com Australia
Mustang Bio stock plunges to 52-week low at $2 - Investing.com
Mustang Bio exits Worcester facility, sells assets to AbbVie By Investing.com - Investing.com Australia
Mustang Bio stock plunges 29% on lease termination news (MBIO:NASDAQ) - Seeking Alpha
Mustang Bio exits lease for Massachusetts facility, divests equipment - TipRanks
Mustang Bio to Exit Lease of Worcester, Mass. Manufacturing Facility -February 27, 2025 at 05:49 pm EST - Marketscreener.com
Mustang Bio to Exit Lease of Worcester, Mass. Manufacturing Facility - MarketWatch
Mustang Bio exits Worcester facility, sells assets to AbbVie - Investing.com
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - The Manila Times
Can Mustang Bio's $3M Financial Boost From Facility Exit Revitalize Its Cancer Therapy Pipeline? - StockTitan
Mustang Bio secures shareholder nod for warrant share issuance By Investing.com - Investing.com South Africa
Mustang Bio secures shareholder nod for warrant share issuance - Investing.com India
CI Financial Corp (CIX:CA): Stock Forecast and Q4 2024 Earnings Report - The Globe and Mail
Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline - Investing.com Australia
Mustang Bio sells assets and ends lease with AbbVie - MSN
Mustang Bio Sells Assets to AbbVie, Transfers Lease - TipRanks
Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline By Investing.com - Investing.com South Africa
Mustang Bio regains compliance with Nasdaq minimum bid price requirement - MSN
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Manila Times
Mustang Bio, Inc. Regains Compliance with Nasdaq Listing Requirements Following Recent Public Offering - Nasdaq
Nasdaq Compliance Alert: Mustang Bio Clears Major Hurdle with $2.5M Equity Milestone - StockTitan
Mustang Bio Closes $8 Million Public Offering - citybiz
Mustang Bio, Inc. Completes Public Offering, Raising Approximately $8 Million for Cancer Cell Therapy Development - Nasdaq
Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewswire
Mustang Bio (MBIO) Secures Critical $8M Financing Through Strategic Share Offering - StockTitan
Mustang Bio sets terms for $8M public offering - MSN
Mustang Bio Inc Azioni (MBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.28%
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):